Solution NMR conformation of glycosaminoglycans

Progress in Biophysics and Molecular Biology

Volumn 114, Issue 2, 2014, Pages 61-68

  Pomin, Vitor H ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Chemical shift anisotropy; Glycosaminoglycans; Nuclear Overhauser effect; Residual dipolar coupling; Scalar coupling

Indexed keywords

GLYCOSAMINOGLYCAN; SOLUTION AND SOLUBILITY;

CHEMISTRY; CONFORMATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; SOLUTION AND SOLUBILITY;

CARBOHYDRATE CONFORMATION; GLYCOSAMINOGLYCANS; MAGNETIC RESONANCE SPECTROSCOPY; SOLUTIONS;

EID: 84899060063     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2014.01.001     Document Type: Review

References (57)

1. Angulo J., Hricovíni M., Gairi M., Guerrini M., de Paz J.L., Ojeda R., Martín-Lomas M., Nieto P.M. Dynamic properties of biologically active synthetic heparin-like hexasaccharides. Glycobiology 2005, 15:1008-1015.
2. Almond A., Sheehan J.K. Glycosaminoglycans conformation: do aqueous molecular dynamics simulations agree with x-ray fiber diffraction?. Glycobiology 2000, 10:329-338.
3. Almond A. Hyaluronan. Cell. Mol. Life Sci. 2007, 64:1591-1596.
4. Almond A., Deangelis P.L., Blundell C.D. Hyaluronan: the local solution conformation determined by NMR and Computer modeling is close to a contracted left-handed 4-fold helix. J.Mol. Biol. 2006, 358:1256-1269.
5. Blanchard V., Chevalier F., Imberty A., Leeflang B.R., Basappa, Sugahara K., Kamerling J.P. Conformational studies on five octasaccharides isolated from chondroitin sulfate using NMR spectroscopy and molecular modeling. Biochemistry 2007, 46:1167-1175.
6. Cael J.J., Winter W.T., Arnott S. Calcium chondroitin 4-sulfate: molecular conformation and organization of polysaccharide chains in a proteoglycan. J.Mol. Biol. 1978, 125:21-42.
7. Cros S., Petitou M., Sizun P., Pérez S., Imberty A. Combined NMR and molecular modeling study of an iduronic acid-containing trisaccharide related to antithrombotic heparin fragments. Bioorg. Med. Chem. 1997, 5:1301-1309.
8. Ferro D.R., Provasoli A., Ragazzi M., Torri G., Casu B., Gatti G., Jacquinet J.C., Sinay P., Petitou M., Choay J. Evidence for conformational equilibrium of the sulfated L-iduronate residue in heparin and in synthetic heparin mono- and oligo-saccharides: NMR and force-field studies. J.Am. Chem. Soc. 1986, 108:6773-6778.
9. Ferro D.R., Provasoli A., Ragazzi M., Casu B., Torri G., Bossennec V., Perly B., Sinaÿ P., Petitou M., Choay J. Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences. Carb. Res. 1990, 195:157-167.
10. Gandhi N.S., Mancera R.L. The structure of glycosaminoglycans and their interactions with proteins. Chem. Biol. Drug. Des. 2008, 72:455-482.
11. García-Mayoral M.F., Canales A., Díaz D., López-Prados J., Moussaoui M., de Paz J.L., Angulo J., Nieto P.M., Jiménez-Barbero J., Boix E., Bruix M. Insights into the glycosaminoglycan-mediated cytotoxic mechanism of eosinophil cationic protein revealed by NMR. Glycobiology 2012, 8:144-151.
12. Gargiulo V., Morando M.A., Silipo A., Nurisso A., Pérez S., Imberty A., Cañada F.J., Parrilli M., Jiménez-Barbero J., De Castro C. Insights on the conformational properties of hyaluronic acid by using NMR residual dipolar couplings and MD simulations. Glycobiology 2010, 10:1208-1216.
13. Hileman R.E., Fromm J.R., Weiler J.M., Linhardt R.J. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 1998, 20:156-167.
14. Hricovíni M. Effect of solvent and counterions upon structure and NMR spin-spin coupling constants in heparin disaccharide. J.Phys. Chem. 2011, 115:1503-1511.
15. Hricovíni M., Bízik F. Relationship between structure and three-bond proton-proton coupling constants in glycosaminoglycans. Carb. Res. 2007, 342:779-783.
16. Hricovíni M., Scholtzová E., Bízik F. B3LYP/6-311++G*study of structure and spin-spin coupling constant in heparin disaccharide. Carb. Res. 2007, 342:1350-1356.
17. Hricovíni M., Torri G. Dynamics in aqueous solutions of the pentasaccharide corresponding to the binding site of heparin for antithrombin III studied by NMR relaxation measurements. Carb. Res. 1995, 268:159-175.
18. Hricovíni M., Guerrini M., Bisio A., Torri G., Petitou M., Casu B. Conformation of heparin pentasaccharide bound to antithrombin III. Biochem. J. 2001, 359:265-272.
19. Holmbeck S.M.A., Petillo P.A., Lerner L.E. The solution conformation of hyaluronan: a combined NMR and molecular dynamics study. Biochemistry 1994, 33:14246-14255.
20. Imberty A., Lortat-Jacob H., Pérez S. Structural view of glycosaminoglycan-protein interactions. Carb. Res. 2007, 342:430-439.
21. Inoue Y., Inoue Y., Nagasawa K. Conformation equilibria of the L-iduronate residue in non-sulphated di-, tetra-, and hexa-saccharides and their alditols derived from dermatan sulphate. Biochem. J. 1990, 265:533-538.
22. Jin L., Abrahams J.P., Skinner R., Petitou M., Pike R.N., Carrell R.W. The anticoagulant activation of antithrombin by heparin. Proc. Nat. Acad. Sci. 1997, 94:14683-14688.
23. Jin L., Hricovíni M., Deakin J.A., Lyon M., Uhrín D. Residual dipolar coupling investigation of a heparin tetrasaccharide confirms the limited effect of flexibility of the iduronic acid on the molecular shape of heparin. Glycobiol. 2009, 19:1185-1196.
24. Karplus M. Contact electron-spin coupling of nuclear magnetic moments. J.Chem. Phys. 1959, 30:11-15.
25. Karplus M. Vicinal proton coupling in nuclear magnetic resonance. J.Am. Chem. Soc. 1963, 85:2870-2871.
26. La Ferla B., Lay L., Guerrini M., Poletti L., Panza L., Russo G. Synthesis of disaccharidic sub-units of a new series of heparin related oligosaccharidesv. Tetrahedron 1999, 55:9867-9880.
27. Lindahl U., Hook M. Glycosaminoglycans and their binding to biological macromolecules. Ann. Rev. Biochem. 1978, 47:385-417.
28. Maruyama T., Toida T., Imanari T., Yu G., Linhardt R.J. Conformational changes and antcoagulant activity of chondroitin sulfate following its O-sulfonation. Carb. Res. 1998, 306:35-43.
29. Michel G., Pojasek K., Li Y.G., Sulea T., Linhardt R.J., Raman R., Prabhakar V., Sasisekharan R., Cygler M. The structure of chondroitin B lyase complexed with glycosaminoglycan oligosaccharides unravels a calcium-dependent catalytic machinery. J.Biol. Chem. 2004, 279:32882-32896.
30. Mikhailov D., Linhardt R.J., Mayo K.H. NMR solution conformation of heparin-derived hexasaccharide. Biochem. J. 1997, 15:51-61.
31. Mikhailov D., Mayo K.H., Vlahov I.R., Toida T., Pervin A., Linhardt R.J. NMR solution conformation of heparin-derived tetrasaccharide. Biochem. J. 1996, 15:93-102.
32. Mobli M., Almond A. N-Acetylated amino sugars: the dependence of NMR 3J(HNH2)-couplings on conformation, dynamics and solvent. Org. Biomol. Chem. 2007, 5:2243-2251.
33. Mulloy B., Forster M.J. Conformation and dynamics of heparin and heparan sulfate. Glycobiology 2000, 10:1147-1156.
34. Mulloy B., Forster M.J., Jones C., Davies D.B. N.m.r. and molecular-modelling studies of the solution conformation of heparin. Biochem. J. 1993, 293:849-858.
35. Mulloy B., Forster M.J., Jones C., Drake A.F., Johnson E.A., Davies D.B. The effect of variation of substitution on the solution conformation of heparin: a spectroscopic and molecular modelling study. Carb. Res. 1994, 255:1-26.
36. Murphy K.J., McLay N., Pye D.A. Structural studies of heparan sulfate hexasaccharides: new insights into iduronate conformational behavior. J.Am. Chem. Soc. 2008, 130:12435-12444.
37. Nieto L., Canales Á., Giménez-Gallego G., Nieto P.M., Jiménez-Barbero J. Conformational selection of the AGA* IAM heparin pentasaccharide when bound to the fibroblast growth factor receptor. Chem. Eur. J. 2011, 17:11204-11209.
38. Nieto L., Canales Á., Fernández I.S., Santillana E., González-Corrochano R., Redondo-Horcajo M., Cañada F.J., Nieto P., Martín-Lomas M., Giménez-Gallego G., Jiménez-Barbero J. Heparin modulates the mitogenic activity of fibroblast growth factor by inducing dimerization of its receptor. a 3D view by using NMR. Chembiochem 2013, 14:1732-1744.
39. Pomin V.H. Unravelling Glycobiology by NMR spectroscopy. Glycosylation 2012, InTech, Available from:. http://www.intechopen.com/books/glycosylation/unravelling-glycobiology-by-nmr-spectroscopy, S. Petrescu (Ed.).
40. Pomin V.H., Piquet A.A., Pereira M.S., Mourão P.A. Residual keratan sulfate in chondroitin sulfate formulations for oral administration. Carb. Pol. 2012, 90:839-846.
41. Rabestein D.L. Heparin and heparan sulfate: structure and function. Nat. Prod. Rep. 2002, 19:312-331.
42. Rodríguez-Carvajal M.A., Imberty A., Pérez S. Conformational behavior of chondroitin and chondroitin sulfate in relation to their physical properties as inferred by molecular modeling. Biopolymers 2003, 69:15-28.
43. Rudd T.R., Guimond S.E., Skidmore M.A., Duchesne L., Guerrini M., Torri G., Cosentino C., Brown A., Clarke D.T., Turnbull J.E., Fernig D.G., Yates E.A. Influence of substitution pattern and cation binding on conformation and activity in heparin derivatives. Glycobiology 2007, 17:983-993.
44. Sattelle B.M., Shakeri J., Almond A. Does microsecond sugar ring flexing encode 3D-shape and bioactivity in the heparanome?. Biomacromolecules 2013, 14:1149-1159.
45. Sattelle B.M., Shakeri J., Roberts I.S., Almond A. A3D-structural model of unsulfated chondroitin from high-field NMR: 4-sulfation has little effect on backbone conformation. Carb. Res. 2010, 345:291-302.
46. Sasisekharan R., Venkataraman G. Heparin and heparan sulfate: biosynthesis, structure and function. Curr. Opin. Chem. Biol. 2000, 4:626-631.
47. Schwieters C.D., Kuszewski J.J., Tjandra N., Clore G.M. The Xplor-NIH NMR molecular structure determination package. J.Magn. Res. 2003, 160:65-73.
48. Schwieters C.D., Kuszewski J.J., Clore G.M. Using Xplor-NIH for NMR molecular structure determination. Prog. Nuc. Magn. Res. Spec. 2006, 48:47-62.
49. Silipo A., Zhang Z., Cañada F.J., Molinaro A., Linhardt R.J., Jiménez-Barbero J. Conformational analysis of a dermatan sullfate-derived tetrasaccharide by NMR, molecular modeling, and residual dipolar coupling. Chembiochem 2008, 9:240-252.
50. Spillmann D., Lindahl U. Glycosaminoglycan-protein interactions: a question of specificity. Curr. Opin. Struc. Biol. 1994, 4:677-682.
51. Sugahara K., Kitagawa H. Heparin and heparan sulfate biosynthesis. IUBMB Life 2002, 54:163-175.
52. Sugahara K., Mikami T., Uyama T., Mizuguchi S., Nomura K., Kitagawa H. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr. Opin. Struct. Biol. 2003, 13:612-620.
53. Valafar H., Prestegard J.H. REDCAT: a residual dipolar coupling analysis tool. J.Magn. Res. 2004, 167:228-241.
54. Winter W.T., Smith P.J.C., Arnott S. Hyaluronic acid: structure of a fully extended 3-fold helical sodium salt and comparison with the less extended 4-fold helical forms. J.Mol. Biol. 1975, 99:219-235.
55. 13C-labeled acetyl groups. J.Am. Chem. Soc. 2007, 129:13288-13297.
56. Zhang Z., McCallum S.A., Xie J., Nieto L., Corzana F., Jiménez-Barbero J., Chen M., Liu J., Linhardt R.J. Solution structures of chemoenzymatically synthesized heparin and its precursors 2008, 130:12998-13007.
57. Zsiska M., Meyer B. Influence of sulfate and carboxylate groups on the conformation of chondroitin sulfate related disaccharides. Carb. Res. 1993, 243:225-258.